Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Griesinger

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Human Reproduction Update|January 5, 2018
GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusionsEfstratios M Kolibianakis, Georg Griesinger, Christos A Venetis
Plos One|March 19, 2016
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III TrialsJakob Doblinger, Barbara Cometti, Silvia Trevisan, et al.
Reproductive Biomedicine Online|April 28, 2020
Characterization of early pregnancy placental progesterone production by use of dydrogesterone in programmed frozen-thawed embryo transfer cyclesKay Neumann, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Human Reproduction (Oxford, England)|March 24, 2017
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilizationHerman Tournaye, Gennady T Sukhikh, Elke Kahler, et al.
Fertility and Sterility|August 10, 2010
Ongoing pregnancy after human menopausal gonadotropin stimulation and timed intercourse in a 40-year-old woman with undetectable antimüllerian hormone levelsTim Cordes, Askan Schultze-Mosgau, Klaus Diedrich, et al.
Clinical Chemistry and Laboratory Medicine|March 7, 2019
Introduction of a novel ELISA assay for serum AMH determinationKay Neumann, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Therapeutische Umschau. Revue Therapeutique|December 2, 2009
[Significance of reproductive medicine in regard to judicial and ethical concerns in Germany]Daniel A Beyer, Feriel Amari, Klaus Diedrich, et al.
Human Reproduction (Oxford, England)|September 24, 2017
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilizationHerman Tournaye, Gennady T Sukhikh, Elke Kahler, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 12, 2018
Comparison of the follicular output rate after controlled ovarian stimulation with daily recombinant follicle-stimulating hormone versus corifollitropin alfaGeorg Griesinger, Valerie Teal, Christine McCrary Sisk, et al.
Reproductive Biomedicine Online|August 18, 2020
Strong variation in progesterone production of the placenta in early pregnancy - what are the clinical implications?Kay Neumann, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Human Reproduction Update|January 5, 2018
GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusionsEfstratios M Kolibianakis, Georg Griesinger, Christos A Venetis
Plos One|March 19, 2016
Subcutaneous Progesterone Is Effective and Safe for Luteal Phase Support in IVF: An Individual Patient Data Meta-Analysis of the Phase III TrialsJakob Doblinger, Barbara Cometti, Silvia Trevisan, et al.
Reproductive Biomedicine Online|April 28, 2020
Characterization of early pregnancy placental progesterone production by use of dydrogesterone in programmed frozen-thawed embryo transfer cyclesKay Neumann, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Human Reproduction (Oxford, England)|March 24, 2017
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilizationHerman Tournaye, Gennady T Sukhikh, Elke Kahler, et al.
Fertility and Sterility|August 10, 2010
Ongoing pregnancy after human menopausal gonadotropin stimulation and timed intercourse in a 40-year-old woman with undetectable antimüllerian hormone levelsTim Cordes, Askan Schultze-Mosgau, Klaus Diedrich, et al.
Clinical Chemistry and Laboratory Medicine|March 7, 2019
Introduction of a novel ELISA assay for serum AMH determinationKay Neumann, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Therapeutische Umschau. Revue Therapeutique|December 2, 2009
[Significance of reproductive medicine in regard to judicial and ethical concerns in Germany]Daniel A Beyer, Feriel Amari, Klaus Diedrich, et al.
Human Reproduction (Oxford, England)|September 24, 2017
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilizationHerman Tournaye, Gennady T Sukhikh, Elke Kahler, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 12, 2018
Comparison of the follicular output rate after controlled ovarian stimulation with daily recombinant follicle-stimulating hormone versus corifollitropin alfaGeorg Griesinger, Valerie Teal, Christine McCrary Sisk, et al.
Reproductive Biomedicine Online|August 18, 2020
Strong variation in progesterone production of the placenta in early pregnancy - what are the clinical implications?Kay Neumann, Marion Depenbusch, Askan Schultze-Mosgau, et al.
Pageof 12